Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Watts

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Delivery|November 22, 2005
TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tractPeter Watts, Alan Smith
Expert Opinion on Drug Delivery|May 6, 2009
PecSys: in situ gelling system for optimised nasal drug deliveryPeter Watts, Alan Smith
Complementary Therapies in Clinical Practice|July 14, 2012
The rise and fall of complementary medicine in National Health Service hospitals in EnglandSarah Cant, Peter Watts, Annmarie Ruston
Social Science & Medicine (1982)|January 7, 2011
Negotiating competency, professionalism and risk: the integration of complementary and alternative medicine by nurses and midwives in NHS hospitalsSarah Cant, Peter Watts, Annmarie Ruston
Drug Delivery and Translational Research|March 20, 2015
Nasal delivery of fentanylPeter Watts, Alan Smith, Michael Perelman
Expert Opinion on Drug Delivery|June 20, 2012
Chitosan-based delivery systems for mucosal vaccinesInderjit Jabbal-Gill, Peter Watts, Alan Smith
Toxicology Research|October 30, 2024
The cliff-edge of toxicological concern: highlighting the potential issues of an over-reliance on "less-than-lifetime" thresholdsChristopher J Waine, Peter Watts, James Hopkins
Biochemical and Biophysical Research Communications|June 29, 2016
Insight into the relationship between the cell culture model, cell trafficking and siRNA silencing efficiencyVictoria Capel, Driton Vllasaliu, Peter Watts, et al.
Journal of Medical Virology|June 25, 2005
The impact of high risk human papillomavirus testing in an inner London colposcopy clinicChris Perrons, Nicola Brink, Hamid Jalal, et al.
Drug Development and Industrial Pharmacy|July 19, 2012
Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and dripJonathan Castile, Yu-Hui Cheng, Ben Simmons, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Delivery|November 22, 2005
TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tractPeter Watts, Alan Smith
Expert Opinion on Drug Delivery|May 6, 2009
PecSys: in situ gelling system for optimised nasal drug deliveryPeter Watts, Alan Smith
Complementary Therapies in Clinical Practice|July 14, 2012
The rise and fall of complementary medicine in National Health Service hospitals in EnglandSarah Cant, Peter Watts, Annmarie Ruston
Social Science & Medicine (1982)|January 7, 2011
Negotiating competency, professionalism and risk: the integration of complementary and alternative medicine by nurses and midwives in NHS hospitalsSarah Cant, Peter Watts, Annmarie Ruston
Drug Delivery and Translational Research|March 20, 2015
Nasal delivery of fentanylPeter Watts, Alan Smith, Michael Perelman
Expert Opinion on Drug Delivery|June 20, 2012
Chitosan-based delivery systems for mucosal vaccinesInderjit Jabbal-Gill, Peter Watts, Alan Smith
Toxicology Research|October 30, 2024
The cliff-edge of toxicological concern: highlighting the potential issues of an over-reliance on "less-than-lifetime" thresholdsChristopher J Waine, Peter Watts, James Hopkins
Biochemical and Biophysical Research Communications|June 29, 2016
Insight into the relationship between the cell culture model, cell trafficking and siRNA silencing efficiencyVictoria Capel, Driton Vllasaliu, Peter Watts, et al.
Journal of Medical Virology|June 25, 2005
The impact of high risk human papillomavirus testing in an inner London colposcopy clinicChris Perrons, Nicola Brink, Hamid Jalal, et al.
Drug Development and Industrial Pharmacy|July 19, 2012
Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and dripJonathan Castile, Yu-Hui Cheng, Ben Simmons, et al.
Pageof 3